Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia

Clinical trial NCT06187285 · COMPLETED

Trial details

NCT number: NCT06187285
Sponsor: Medanta, The Medicity, India
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2024-01-01
Primary completion: 2025-05-01
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.